|
gptkb:infliximab
|
can induce anti-drug antibodies
|
|
gptkb:obinutuzumab
|
low
|
|
gptkb:interferon_beta-1a
|
may induce neutralizing antibodies
|
|
gptkb:RhCc_antigen
|
moderate
|
|
gptkb:virus
|
low
|
|
gptkb:emicizumab
|
low
|
|
gptkb:OKT3
|
can induce human anti-mouse antibodies (HAMA)
|
|
gptkb:adenovirus_serotype_26_(Ad26)
|
moderate
|
|
gptkb:adalimumab
|
low
|
|
gptkb:cetuximab
|
can cause allergic reactions
|
|
gptkb:RhD_antigen
|
high
|
|
gptkb:ipilimumab
|
low
|
|
gptkb:Prolia
|
low
|
|
gptkb:nivolumab
|
low
|
|
gptkb:cAd3-ZEBOV
|
induces immune response against Ebola virus
|
|
gptkb:Darzalex
|
low
|
|
gptkb:Ipilimumab
|
low
|
|
gptkb:Interferon_beta-1a
|
may induce neutralizing antibodies
|
|
gptkb:Nivolumab
|
low
|
|
gptkb:pertuzumab
|
low
|